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Background: Herpes zoster ophthalmicus is defined as herpes zoster involvement of the ophthalmic division of
the trigeminal nerve. Ocular involvement occurs in 20–70% of patients with herpes zoster ophthalmicus and may
include blepharitis, keratoconjunctivitis, iritis, scleritis, and acute retinal necrosis. Orbital apex syndrome is a rare but
severe ocular complication of herpes zoster ophthalmicus. We present here the first reported case of herpes zoster
ophthalmicus complicated by orbital apex syndrome in a patient from Taiwan.
Case presentation: A 78-year-old man initially presented with patchy erythema and herpetiform vesicles on his left
forehead and upper eyelid. He subsequently developed left-sided ocular complications including reduced visual
acuity, anisocoria, ptosis, and complete ophthalmoplegia. Orbital magnetic resonance imaging (MRI) was performed
on day 6 of admission to search for signs of the common causes of orbital apex syndrome such as hemorrhage,
neoplasm, and cavernous sinus thrombosis. The MRI showed only orbital myositis and enhancement of the
retro-orbital optic nerve sheath. The patient was diagnosed with herpes zoster ophthalmicus complicated by
orbital apex syndrome. Although the ocular complications partially resolved after systemic antiviral therapy for
15 days and steroid therapy tapered over 12 weeks, there was residual limitation of abduction and paralysis
of the left upper eyelid at follow-up at 180 days after the onset of symptoms. The orbital MRI findings at 180
days showed no significant changes compared with the MRI findings on day 6 of admission.
Conclusions: Primary care physicians should be aware of this rare but potentially sight-threatening complication of
herpes zoster ophthalmicus. The appropriate therapy for orbital apex syndrome due to herpes zoster ophthalmicus and
the potential outcomes of this condition require further investigation.
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Herpes zoster is a unilateral vesicular eruption with a
dermatomal distribution that results from reactivation of
latent varicella zoster virus (VZV) infection of the dorsal
root ganglia. Herpes zoster ophthalmicus (HZO) is caused
by reactivation of latent VZV infection in the trigeminal
ganglion, involving the ophthalmic division of the trigemi-
nal nerve (V1). The reported mean time to the onset of
ocular involvement is 1.82 weeks (range, 1–4 weeks) after
the start of skin lesions in the V1 dermatome [1]. Ocular
involvement occurs in 20–70% of patients with HZO* Correspondence: u9371003@gmail.com
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unless otherwise stated.[1,2], and may include blepharitis, keratoconjunctivitis, ir-
itis, scleritis, and acute retinal necrosis. Neurological com-
plications are less frequent than ocular complications, and
may include ophthalmoplegia, optic neuritis, ptosis, and
(rarely) orbital apex syndrome (OAS) [3]. OAS involves
dysfunction of V1, the oculomotor nerve (III), the troch-
lear nerve (IV), and the abducens nerve (VI), as well as
dysfunction of the optic nerve (II). The causes of OAS
include a variety of inflammatory, infectious, neoplastic,
iatrogenic/traumatic, and vascular conditions. Aspergil-
losis and mucormycosis are the most common infectious
causes of OAS, and VZV is rarely considered as a cause.
We present here the first reported case of HZO compli-
cated by OAS in a patient from Taiwan.is is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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A 78-year-old man presented to an ophthalmology clinic
complaining of a gritty sensation in both eyes for several
months, with exacerbation in the left eye over the past 2
weeks. He had a history of diabetes mellitus treated with
oral hypoglycemic drugs and chronic obstructive pulmon-
ary disease. He was diagnosed with background diabetic
retinopathy. Examination using a Snellen chart showed a
visual acuity of 6/12 in both eyes, meaning that he would
need to approach to a distance of 6 meters to read letters
that a person with normal acuity would be able to read at
12 meters. The patient noticed pain and swelling of his left
eyelid at that time, and developed headache and vomiting
1 week later. Five days before admission, he developed
patchy erythema with clustered vesicles with varying sizes
on his left forehead and upper eyelid. On the day of ad-
mission, he developed drooping of the left upper eyelid,
and was admitted to the infectious diseases ward with a
diagnosis of HZO in the distribution of V1 on the left side,
complicated by superficial punctate keratitis.
The patient was initially treated with intravenous acyclo-
vir (500 mg every 8 hours), topical antiviral ointment
(acyclovir 3%), and non-steroidal anti-inflammatory drugs
to relieve the pain caused by severe swelling and erythema
of his left upper eyelid. On day 4 of admission, the inflam-
mation of the left upper eyelid had resolved, but he was
still unable to elevate the eyelid. Physical examination
showed markedly crusted skin lesions in the distributionFigure 1 Eye positions in each direction of gaze (arrows). a On day 4
the left side. b After 12 weeks of treatment, the ocular movements were mof V1 on the left side, with a positive Hutchinson’s sign
and complete levator paralysis. Examination of the extrao-
cular movements with the eyelids held open showed near-
complete ophthalmoplegia on the left side (Figure 1a). His
visual acuity was 6/12 on the right side and 3/60 on the
left side. He had anisocoria with the left pupil, which was
poorly reactive to light and accommodation, measuring
up to 6 mm in diameter. He was diagnosed with OAS,
and brain magnetic resonance imaging (MRI) on day 5 of
admission showed swelling of the left periorbital tissues
and left-sided exophthalmos, with no evidence of a retro-
orbital space-occupying lesion. Orbital fat-suppressed
MRI on day 6 of admission showed orbital myositis and
enhancement of the optic nerve sheath (Figure 2a).
The patient was diagnosed with HZO complicated by
OAS, and systemic steroid therapy was initiated on day
6 of admission. Adduction and supraduction of the left
eye started to improve on day 3 after the initiation of
steroid therapy. He received intravenous acyclovir (500
mg every 8 hours) for 15 days, and oral prednisolone (25
mg twice daily; >1 mg/kg per day) for 4 days followed by
12 weeks of prednisolone therapy that was tapered at
monthly visits. The patient was discharged after comple-
tion of the acyclovir therapy. His visual acuity recovered
to 6/12 on the right side and 6/30 on the left side, and
his extraocular movements gradually improved, with re-
sidual limitation of abduction and paralysis of the left
upper eyelid at the completion of the steroid therapyof admission, there was near-complete ophthalmoplegia and ptosis on
arkedly improved, except for abduction.
Figure 2 Orbital MRI findings. a On day 6 of admission, there was enhancement and swelling of the left extraocular muscles (arrows) on
T2-weighted images; and mild enhancement of the left optic nerve sheath (arrowhead), left posterior orbital wall, and left orbital apex
on contrast-enhanced T1-weighted images. b At 180 days after the onset of symptoms, there were no significant changes compared
with the MRI findings on day 6 of admission.
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symptoms showed persistent limitation of abduction and
paralysis of the left upper eyelid. Repeat orbital MRI
at 180 days showed no changes to the orbital lesions
compared with the MRI findings on day 6 of admis-
sion (Figure 2b).
Discussion
The present case illustrates a rare but severe complica-
tion of HZO, which was not initially recognized because
of ptosis and severe dermatitis of the left upper eyelid.
Orbital MRI excluded other common causes of OAS such
as hemorrhage, neoplasm, and cavernous sinus throm-
bosis, and showed orbital myositis and enhancement of
the retro-orbital optic nerve sheath. Adduction and supra-
duction of the left eye started to improve on day 3 after
the initiation of steroid therapy. Although the patient re-
ceived systemic acyclovir therapy for 15 days, and high-
dose systemic steroid therapy that was tapered over 12
weeks, there was residual limitation of abduction and par-
alysis of the left upper eyelid at follow-up at 180 days after
the onset of symptoms.
The diagnosis of herpes zoster is usually based on clin-
ical findings. However, clinical differentiation between
VZV and zosteriform herpes simplex virus lesions maybe difficult. Laboratory investigations such as viral cul-
tures, antigen detection, and molecular techniques can re-
liably differentiate between these two conditions. Some
clinical findings such as the patterns of clustering and re-
currence of vesicles can also help to differentiate between
the two conditions. The vesicles are uniform in size in
herpes simplex infection, and vary in size in VZV infection
[4]. Only 4% of patients with VZV infection experience a
second episode of vesicles, whereas zosteriform herpes
simplex virus lesions tend to recur [5,6]. Although we did
not perform laboratory investigations to detect VZV, we
consider that our patient was more likely to have VZV
lesions than zosteriform herpes simplex virus lesions be-
cause of the lack of recurrence during 6 months of follow-
up and the varying sizes of vesicles in the clusters.
Mucormycosis and aspergillosis are the most common
infectious causes of OAS, and should be suspected in pa-
tients with predisposing conditions such as diabetes mellitus,
alcoholism, hematologic malignancy, and immunosuppres-
sion. The primary infection occurs in the paranasal sinuses,
with direct invasion into the orbital cavity [7]. Another in-
fectious cause of OAS is bacterial infection of the parana-
sal sinuses complicated by cavernous sinus thrombosis.
The most commonly implicated bacteria are Staphylococcus
aureus, Streptococcus pneumoniae, and other streptococci.
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the clinical manifestations, host factors, and radiological
findings. Reactivation of latent VZV infection rarely pre-
sents as OAS, and presentation with ocular muscle palsy
is uncommon in HZO. In the Mayo Clinic series, 3 of 86
patients with HZO (3.4%) had extraocular muscle palsy,
with cranial nerve IV dysfunction in 2 patients and cranial
nerve VI dysfunction in 1 patient [8]. In the Moorfield Eye
Hospital study, 133 of 1356 patients with HZO (9.8%) had
extraocular muscle palsy, with cranial nerve III dysfunc-
tion in 4 of the patients [9]. The incidence of cranial nerve
II dysfunction was even lower, occurring in only 0.4% of
the patients in the Moorfield Eye Hospital study [9]. HZO
complicated by OAS, which is also known as optic neur-
itis/neuropathy associated with complete ophthalmople-
gia, was first reported by Ramsell [10]. To the best of our
knowledge, this is the first reported case of HZO compli-
cated by OAS in a patient from Taiwan. Most previously
reported cases of OAS due to HZO were in patients aged
over 60 years [10-14], and one case occurred in a 29-year-
old woman with severe immunological dysfunction be-
cause of acquired immunodeficiency syndrome [15]. In
most cases, OAS developed within 3 weeks of the onset of
a herpetic skin eruption [10-14].
Although the optimal therapy for OAS due to HZO
remains unclear, the current mainstay of treatment is
combined administration of systemic acyclovir and ste-
roids [11-15]. The effectiveness of acyclovir therapy may
have been reduced in our patient because of the delay in
initiation of treatment. The optimal time for initiation of
treatment is within 72 hours of the onset of the rash [5],
but our patient did not receive acyclovir until 5 days
after the onset of patchy erythema with herpetiform vesi-
cles. In addition, the role of systemic corticosteroid ther-
apy remains controversial. In our patient, adduction and
supraduction started to improve on day 3 after the initi-
ation of steroid therapy, but further improvement of the
extraocular movements and ptosis was minimal, with re-
sidual limitation of abduction and paralysis of the left
upper eyelid after 12 weeks of systemic steroid therapy.
Orbital MRI at 180 days after the onset of symptoms
showed continued swelling of the left extraocular muscles
and mild enhancement of the left optic nerve sheath. Re-
sidual limitation of extraocular movements was also re-
ported in other cases [12,14]. The proportion of patients
who achieve resolution of ptosis, ophthalmoplegia, and re-
duced visual acuity remains unknown. Complete or near-
complete resolution of ophthalmoplegia due to HZO has
been reported to occur in 76.5% of cases, and may take
between 2 weeks and 1.5 years (mean, 4.4 months) [3].
The mechanisms by which optic neuropathy and extrao-
cular muscle paralysis develop in patients with OAS due to
HZO are not completely understood. Possible mechanisms
include extensive inflammation around the posterior ciliarynerves and vessels with ocular ischemia [16], orbital soft
tissue edema with direct compression of cranial nerves III,
IV, and VI [17], and direct spread of VZV from cranial
nerve V to cranial nerves III, IV, and VI [18]. Different
mechanisms may result in different prognoses [9].
Conclusions
OAS is a rare but severe complication of HZO. Primary
care physicians should be aware of this complication and
should monitor patients carefully during the first 3 weeks
after the onset of HZO. Orbital MRI should be performed
to exclude more common causes of OAS. Further stud-
ies are needed to evaluate the appropriate therapy for
OAS due to HZO, and the potential outcomes of this
rare complication.
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